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Terminal deletions of chromosome 6q are rare. Clinical features associated with 6q 
terminal deletion syndrome include psychomotor retardation, seizures, hypotonia, 
short neck, and facial abnormalities, as well as various case-specific anomalies. 
Here, we describe a girl with 6q terminal deletion syndrome and unusually short 
stature. Features of previously described patients are also summarized.
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1. Introduction
Terminal deletions of the long arm of chromosome 
6 (6q) have been associated with mental retar-
dation, hypotonia, seizures, facial dysmorphisms, 
and short neck.1−7 Isolated terminal 6q deletion 
has been described as a distinct syndrome, and ex-
cludes cases with interstitial deletions, deletions/
duplications, ring chromosomes or more complex 
rearrangements. The phenotypes associated with 
these disorders could be the consequence of various 
imbalances, and these genotypes are, therefore, 
considered to differ significantly from the defined 
“6q terminal deletion syndrome”.8 To date, only 
19 cases of isolated 6q terminal deletion have been 
reported.1,6−12 The common findings included facial 
dysmorphism, short neck, psychomotor retardation, 
hypotonia, and seizures. Differences in deletion 
sizes most likely explain the variation in observed 
phenotypes. Unlike many other unbalanced chromo-
some aberrations whose phenotypes include growth 
retardation, the features of 6q terminal deletion 
are frequently nonspecific, such as intrauterine and 
postnatal growth retardation.
We report a patient with a 6q25.3 terminal 
deletion. The patient presented with psychomotor 
retardation, facial dysmorphism, short neck and 
unusually short stature, which has not been reported 
in previous cases of isolated terminal 6q deletion.
2. Case Report
This 14.5-year-old girl was born at term after 
an uneventful second pregnancy from unrelated, 
healthy parents. Birth weight was 2150 g (below 3rd 
centile), length was 48 cm (3rd centile), and head 
circumference was 30 cm (below 3rd centile). The 
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first and third pregnancies had produced healthy 
female and male infants, respectively. Family his-
tory was unremarkable for congenital abnormalities. 
At age of 6 years, this girl demonstrated develop-
mental delay and moderate hypotonia. She had head 
control at 4 months, rolled over at 9 months, main-
tained the sitting position without support at 11 
months, and started to walk at 20 months. She had 
used single words at 15 months and had sphincter 
control at 36 months. However, the anterior fonta-
nelle closed at 4 months, and the patient exhibited 
failure to thrive and frequent diarrhea from 2 weeks 
old. The patient did not experience seizures, but 
mental retardation was present. At the age of 9.5 
years, the girl was referred to our genetic clinic 
for evaluation because of psychomotor retardation 
and short stature. Physical examination revealed 
severe microcephaly (head circumference, 44.5 cm), 
low frontal hairline, hypertelorism, depressed nasal 
root, bulbous tip (Figure 1), large and low-set ears 
(Figure 2), micrognathia, high arched palate, short 
neck, and joint laxity. Weight was 15 kg (below 3rd 
centile) and height was 117.8 cm (below 3rd cen-
tile). A radiograph of the left hand and wrist for 
bone age (BA) determination according to the stand-
ards of Greulich and Pyle13 was obtained at 6.5 
years of age (BA > 2 SDs below the mean for age is 
considered delayed). Growth hormone (GH) release 
was determined using clonidine and L-dopa for pro-
vocative tests. GH was measured14 by radioimmu-
noassay, and the peak GH levels were 4.6 ng/mL and 
5.4 ng/mL using clonidine and L-dopa tests, re-
spectively. The level of insulin-like growth factor 
was 42.7 ng/mL.
Neuropsychologic testing showed mild mental 
retardation (IQ, 53). The girl’s social interactions 
were good, and she was attending a school for men-
tally retarded children. Magnetic resonance imaging 
showed no significant abnormalities. Chromosome 
analysis by GTG banding showed a deletion of the 
long arm of chromosome 6, with a breakpoint at 
6q25.3 (Figure 3). Spectral karyotyping (SKY) fluo-
rescence in situ hybridization was performed using 
multicolor-labeled painting probes from the Applied 
Spectral Imaging SKY paint kit (ASI Inc., Israel) to 
identify chromosomal abnormalities. This revealed 
that no other chromosomal material was present on 
the aberrant chromosome 6 (Figure 4). Comparative 
genomic hybridization was performed to define the 
breakpoints and also revealed that the aberrant 
chromosome 6 had a breakpoint at 6q25.3 (Figure 5). 
According to these data, the final karyotype was 
defined as 46,XX,del(6)(q25.3  qter). The parental 
karyotypes were normal.
After the patient reached 10 years 8 months old, 
she was treated with a standard dose (0.3 mg/kg/
week) of GH. After 4 years of treatment, her growth 
rate, monitored as rate of change in body height, 
was 6 cm/year. At this writing, her BA is 10 years 
and menarche has not yet occurred.
Figure 1 Craniofacial dysmorphism of patient.
Normal(6) Del(6)(q25.3) 
q25.3
Figure 3 Chromosomal analysis showed a deletion of 
the long arm of chromosome 6, with a breakpoint at 
6q25.3.
Figure 2 Large, low-set and malformed ear of patient.
90 P.H. Su et al
3. Discussion
Clinical descriptions of patients with 6q terminal 
deletions have been reported since 1975. Many 
rearrangements involving the terminal region of 
chromosome 6 have been documented, including 
interstitial deletions, unbalanced translocations 
and ring chromosomes, as well as isolated terminal 
deletions.1,6−12,15−22 Bertini et al8 defined the “6q 
terminal deletion syndrome” as a new syndrome 
characterized by specific craniofacial dysmorphisms, 
short neck, and neurologic manifestations, along 
with various nonspecific malformations. These com-
mon phenotypes are individually present in many 
chromosomal syndromes, but considered together, 
they are valuable for the identification of 6q terminal 
deletion syndrome.
Microcephaly is a common feature present in 
almost all patients.8 The ears are large and mal-
formed, and micrognathia, a high arched palate, 
long philtrum and short neck are also reported 
consistently.8 Our patient shared these significant 
craniofacial anomalies. It is interesting to note, 
however, that our patient did not have a “fish-like” 
mouth. Frequently observed neurologic manifesta-
tions include psychomotor retardation, hypotonia, 
and seizures.8 Although our patient presented with 
moderate psychomotor retardation (IQ, 53) and 
joint hyperextensibility, she had neither seizures nor 
brain anomalies such as dilatation of ventricles, agen-
esis or hypoplasia of the corpus callosum. Previous 
reports have suggested that vertebral anomalies 
and congenital heart and retinal defects are rela-
tively common in patients with 6q deletions,1,3,6,7 
but we failed to identify these features in our pa-
tient. Features documented in previously described 
patients, in comparison with the current case, are 
summarized in the Table.
It is interesting that growth retardation has often 
been associated with distal deletions of 6q,23 but 
is not included in the characteristics of isolated 6q 
Figure 4 Spectral karyotyping fluorescence in situ hybrid-
ization indicated that no other chromosomal material 
was present on the aberrant chromosome 6.
Figure 5 Comparative genomic hybridization was performed to define the breakpoints and revealed that the aberrant 
chromosome 6 had a breakpoint at 6q25.3.
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deletion syndrome.8 To our knowledge, GH deficiency 
has never previously been reported in a patient 
with 6q deletion. There have also been no reports 
on the effects of GH treatment in these patients. 
During 5 years of follow-up of our patient, there 
was a significant increase in the rate of change of 
body height from 3.8 cm/year to 6 cm/year before 
and after GH replacement, respectively. The cost−
benefit of GH therapy in a girl with chromosome 
anomaly and moderate mental retardation is con-
troversial, but the body image confidence benefit 
is significant.
To correlate phenotype with genotype, Hopkin 
et al1 divided 6q deletions into three groups: (1)
group A [del (6)(q11q16)], showing microcephaly, 
up-slanting palpebral fissures, thin lips, micrognathia, 
heart malformations and hernia; (2) group B [del 
(6)(q15q25)], showing intrauterine growth retar-
dation, hypertelorism, upper limb malformations 
and respiratory problems; and (3) group C [del (6)
(q25qter)], showing retinal abnormalities, cleft pal-
ate and genital hypoplasia. The common findings 
in all three groups were mental retardation, ear 
anomalies, hypotonia, and postnatal growth retar-
dation. Bertini et al8 described band q25 as the 
most common location for breakpoints in patients 
with 6q terminal deletions. However, it has to be 
noted that 6q26 is a region characterized by a 
common fragile site, FRA6E (6q26), and that the 
fragility extends over a large region ranging from 
6q25.3 to 6q26 (3.6 Mb).24 Because all fragile sites 
are characterized by a delayed replication time, this 
common feature may be related to their potential 
role in causing constitutional chromosomal deletions.
In summary, this patient had a 6q25.3 deletion, 
typical craniofacial abnormalities, mental retarda-
tion, and growth retardation. GH replacement was 
observed to increase height and may be beneficial 
in similar patients. We, therefore, suggest that: (1) 
high-resolution chromosome analysis is necessary 
in patients with mental retardation combined with 
growth retardation, because the 6q telomeric region, 
like most telomeres, stains lightly with G-banding, 
and small rearrangements are, therefore, difficult 
to detect; and (2) the necessity for recombinant 
human GH replacement must be decided after long-
term follow-up and a GH provocation test.
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